Eric J Shiroma1, Nancy R Cook, Joann E Manson, M V Moorthy, Julie E Buring, Eric B Rimm, I-Min Lee. 1. 1Laboratory of Epidemiology and Population Science, Intramural Research Program of the National Institutes of Health, National Institute on Aging, Bethesda, MD; 2Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; 3Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA; and 4Department of Nutrition, Harvard School of Public Health, Boston, MA.
Abstract
PURPOSE: This study aimed to examine the association of strength training with incident type 2 diabetes and cardiovascular disease risk. METHODS: We followed 35,754 healthy women (mean age = 62.6 yr, range = 47.0-97.8) from the Women's Health Study, who responded to a health questionnaire that included physical activity questions in 2000, assessing health outcomes through annual health questionnaire through 2014 (mean ± SD follow-up = 10.7 ± 3.7 yr). Incident type 2 diabetes (N cases = 2120) and cardiovascular disease (N cases = 1742) were confirmed on medical record review. Cases of cardiovascular disease were defined as confirmed cases of myocardial infarction, stroke, coronary artery bypass graft, angioplasty, or cardiovascular disease death. RESULTS: Compared with women who reported no strength training, women engaging in any strength training experienced a reduced rate of type 2 diabetes of 30% (hazard ratio = 0.70, 95% confidence interval = 0.61-0.80) when controlling for time spent in other activities and other confounders. A risk reduction of 17% was observed for cardiovascular disease among women engaging in strength training (hazard ratio = 0.83, 95% confidence interval = 0.72, 0.96). Participation in both strength training and aerobic activity was associated with additional risk reductions for both type 2 diabetes and cardiovascular disease compared with participation in aerobic activity only. CONCLUSIONS: These data support the inclusion of muscle-strengthening exercises in physical activity regimens for reduced risk of type 2 diabetes and cardiovascular disease, independent of aerobic exercise. Further research is needed to determine the optimum dose and intensity of muscle-strengthening exercises.
PURPOSE: This study aimed to examine the association of strength training with incident type 2 diabetes and cardiovascular disease risk. METHODS: We followed 35,754 healthy women (mean age = 62.6 yr, range = 47.0-97.8) from the Women's Health Study, who responded to a health questionnaire that included physical activity questions in 2000, assessing health outcomes through annual health questionnaire through 2014 (mean ± SD follow-up = 10.7 ± 3.7 yr). Incident type 2 diabetes (N cases = 2120) and cardiovascular disease (N cases = 1742) were confirmed on medical record review. Cases of cardiovascular disease were defined as confirmed cases of myocardial infarction, stroke, coronary artery bypass graft, angioplasty, or cardiovascular disease death. RESULTS: Compared with women who reported no strength training, women engaging in any strength training experienced a reduced rate of type 2 diabetes of 30% (hazard ratio = 0.70, 95% confidence interval = 0.61-0.80) when controlling for time spent in other activities and other confounders. A risk reduction of 17% was observed for cardiovascular disease among women engaging in strength training (hazard ratio = 0.83, 95% confidence interval = 0.72, 0.96). Participation in both strength training and aerobic activity was associated with additional risk reductions for both type 2 diabetes and cardiovascular disease compared with participation in aerobic activity only. CONCLUSIONS: These data support the inclusion of muscle-strengthening exercises in physical activity regimens for reduced risk of type 2 diabetes and cardiovascular disease, independent of aerobic exercise. Further research is needed to determine the optimum dose and intensity of muscle-strengthening exercises.
Authors: Eric L Ding; Yiqing Song; JoAnn E Manson; Aruna D Pradhan; Julie E Buring; Simin Liu Journal: Diabetes Care Date: 2007-09 Impact factor: 19.112
Authors: Jacob Sattelmair; Jeremy Pertman; Eric L Ding; Harold W Kohl; William Haskell; I-Min Lee Journal: Circulation Date: 2011-08-01 Impact factor: 29.690
Authors: Clemens Drenowatz; Xuemei Sui; Stacy Fritz; Carl J Lavie; Paul F Beattie; Timothy S Church; Steven N Blair Journal: J Sci Med Sport Date: 2014-09-22 Impact factor: 4.319
Authors: Mihaela Tanasescu; Michael F Leitzmann; Eric B Rimm; Walter C Willett; Meir J Stampfer; Frank B Hu Journal: JAMA Date: 2002 Oct 23-30 Impact factor: 56.272
Authors: Paul M Ridker; Nancy R Cook; I-Min Lee; David Gordon; J Michael Gaziano; Joann E Manson; Charles H Hennekens; Julie E Buring Journal: N Engl J Med Date: 2005-03-07 Impact factor: 91.245
Authors: W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer Journal: Am J Epidemiol Date: 1985-07 Impact factor: 4.897
Authors: Esmée A Bakker; Duck-Chul Lee; Xuemei Sui; Thijs M H Eijsvogels; Francisco B Ortega; I-Min Lee; Carl J Lavie; Steven N Blair Journal: Mayo Clin Proc Date: 2018-02-08 Impact factor: 7.616
Authors: Yuehan Wang; Duck-Chul Lee; Angelique G Brellenthin; Xuemei Sui; Timothy S Church; Carl J Lavie; Steven N Blair Journal: Mayo Clin Proc Date: 2019-03-11 Impact factor: 7.616
Authors: Kristin Pullyblank; David Strogatz; Sara C Folta; Lynn Paul; Miriam E Nelson; Meredith Graham; Grace A Marshall; Galen Eldridge; Stephen A Parry; Sean Mebust; Rebecca A Seguin Journal: J Rural Health Date: 2019-03-13 Impact factor: 4.333
Authors: Carrie A Karvonen-Gutierrez; Qing Peng; Mark Peterson; Kate Duchowny; Bin Nan; Sioban Harlow Journal: Age Ageing Date: 2018-09-01 Impact factor: 10.668
Authors: Joowon Lee; Baojiang Chen; Harold W Kohl; Carolyn E Barlow; Chong Do Lee; Nina B Radford; Laura F DeFina; Kelley P Gabriel Journal: J Aging Phys Act Date: 2019-12-06 Impact factor: 1.961